HR 985
116th Congress
House
Health
Competition and antitrust
Drug safety, medical device, and laboratory regulation
Licensing and registrations
Prescription drugs
FAST Generics Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2019
Referred to the House Committee on Energy and Commerce.
Feb 5, 2019
Introduced in House
Plain-English summary
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019
This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1
Cosponsors
1